Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

The Role of Family Lawyers in Protecting Children’s Interests

When family relationships break down, decisions about children can become tense quickly. In these matters, the focus is meant to stay on what supports a child’s wellbeing, even when adults feel hurt...

Tidur siang selama puasa Ramadan bantu otak lebih fokus dan berpikir cepat

Odua Images/ShutterstockSelama Ramadan, umat Islam berpuasa dari makan dan minum sebelum subuh hingga waktu berbuka setelah magrib. Ritme unik ini sering kali menyebabkan perubahan pola tidur. Karena ...

Buying Managed IT Services in Australia (Without Paying for Surprises)

Managed IT usually becomes a serious conversation when interruptions start affecting delivery. For most Australian businesses in the 7–100 staff range, that shift happens quietly.  For example, clo...